Breakthrough by Professor Kang Kyung-sun’s Seoul National University research team
Integration of skin–vascular organoid technology
Verification of atopic inflammation induction and treatment response
Professor Kang Kyung-sun
Kangstem Biotech has developed an artificial skin model that reproduces not only the structure of actual human skin but also its vascular and immune functions. In this model, the company induced an inflammatory response similar to atopic dermatitis and confirmed that administration of existing therapeutics alleviated symptoms. The model is expected to be used to identify the causes of skin diseases and evaluate the efficacy of new drug candidates in the future.
Kangstem Biotech announced that it has developed a “vascularized skin assembloid” technology that combines blood vessels and immune cells with skin organoids. The research results were published in the international journal Experimental & Molecular Medicine.
Organoids are a type of “mini-organ” created using stem cells and other sources to reproduce structures and functions similar to those of actual human organs. They are used in laboratories to observe disease development processes and drug responses that are difficult to test directly in humans.
Conventional skin organoids can reproduce the basic structure of skin but have limitations in modeling blood vessels and immune functions, which play crucial roles in real skin. Blood vessels supply oxygen and nutrients to skin tissue, and immune cells respond to external stimuli. Without these components, it is difficult to sufficiently observe the complex pathogenesis of inflammatory skin diseases and responses to therapeutics.
The research team led by Professor Kang Kyung-sun of Seoul National University, Chief Scientific Officer at Kangstem Biotech, addressed this issue by combining skin organoids with vascular organoids. As a result, they implemented a model in which not only the epidermis and dermis, but also hair follicles, nerve-related structures, and vascular networks formed together. Immune cells were additionally introduced, enabling observation of interactions between blood vessels and immune cells within skin tissue.
The team also verified whether the developed artificial skin could reproduce the characteristics of actual skin diseases. First, they treated the model with house dust mite extract to induce an inflammatory response associated with atopic dermatitis. As a result, filaggrin (FLG), a key protein that maintains the skin barrier, decreased, while stress responses in skin cells and immune cell infiltration increased. Levels of inflammatory factors related to atopic dermatitis, such as interleukin (IL)-4 and IL-13, also increased. This indicates that the model goes beyond merely creating a skin-like morphology to reproducing, in the laboratory, the process by which allergic stimuli damage the skin barrier and trigger inflammation.
The researchers then applied upadacitinib and dupilumab, which are used to treat atopic dermatitis, to the artificial skin. Both drugs improved indicators related to the skin barrier and reduced inflammation-related signaling. In particular, both treatments showed a decrease in STAT6 signaling, which is involved in atopic inflammatory responses, aligning with previously known mechanisms of action of these drugs.
This study is significant in that it demonstrates the potential to evaluate not only disease progression but also responses to therapeutics using a laboratory-implemented skin model. However, as the findings were obtained in vitro, additional validation is needed to determine whether drug effects in actual patients can be predicted with the same accuracy.
A Kangstem Biotech official stated, “This study is meaningful in that it goes beyond simply mimicking the appearance of human skin to integrating vascular and immune functions and confirming responses to actual diseases and therapeutics,” adding, “We will develop this into a platform that can be used for research on various skin diseases and for new drug development.”
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
Popular News